JP2017535612A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017535612A5 JP2017535612A5 JP2017545857A JP2017545857A JP2017535612A5 JP 2017535612 A5 JP2017535612 A5 JP 2017535612A5 JP 2017545857 A JP2017545857 A JP 2017545857A JP 2017545857 A JP2017545857 A JP 2017545857A JP 2017535612 A5 JP2017535612 A5 JP 2017535612A5
- Authority
- JP
- Japan
- Prior art keywords
- nasal
- disorder
- preparation
- riluzole
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462083068P | 2014-11-21 | 2014-11-21 | |
| US62/083,068 | 2014-11-21 | ||
| PCT/US2015/061106 WO2016081466A1 (en) | 2014-11-21 | 2015-11-17 | Sublingual administration of riluzole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017535612A JP2017535612A (ja) | 2017-11-30 |
| JP2017535612A5 true JP2017535612A5 (enExample) | 2018-11-01 |
Family
ID=55077617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017545857A Pending JP2017535612A (ja) | 2014-11-21 | 2015-11-17 | リルゾールの舌下投与 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180153862A1 (enExample) |
| EP (1) | EP3220890A1 (enExample) |
| JP (1) | JP2017535612A (enExample) |
| KR (1) | KR20170137030A (enExample) |
| CN (1) | CN107735077A (enExample) |
| AU (1) | AU2015350142A1 (enExample) |
| BR (1) | BR112017010440A2 (enExample) |
| CA (1) | CA2967659A1 (enExample) |
| EA (1) | EA201791110A1 (enExample) |
| IL (1) | IL252283A0 (enExample) |
| MX (1) | MX2017006454A (enExample) |
| PH (1) | PH12017500933A1 (enExample) |
| SG (1) | SG11201703897SA (enExample) |
| WO (1) | WO2016081466A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9925282B2 (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
| AU2014340182B2 (en) | 2013-10-22 | 2019-05-23 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
| RS59490B1 (sr) | 2014-11-21 | 2019-12-31 | Biohaven Therapeutics Ltd | Sublingvalna formulacija riluzola |
| US9899038B2 (en) | 2016-06-30 | 2018-02-20 | Karen Elaine Khaleghi | Electronic notebook system |
| US20190240194A1 (en) | 2016-08-31 | 2019-08-08 | The General Hospital Corporation | Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases |
| RU2021101120A (ru) * | 2016-09-15 | 2022-03-16 | Скинтек Лайф Сайенс Лимитед | Сублингвальное или буккальное введение dim для лечения заболеваний кожи |
| US10751345B2 (en) | 2018-02-21 | 2020-08-25 | AI Therapeutics, Inc. | Combination therapy with apilimod and glutamatergic agents |
| US12589097B2 (en) | 2018-02-21 | 2026-03-31 | OrphAl Therapeutics Inc. | Apilimod compositions and methods of use |
| US10235998B1 (en) | 2018-02-28 | 2019-03-19 | Karen Elaine Khaleghi | Health monitoring system and appliance |
| AU2019251191A1 (en) * | 2018-04-09 | 2020-10-29 | The General Hospital Corporation | Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders |
| CN112203692A (zh) * | 2018-05-27 | 2021-01-08 | 拜尔哈文制药股份有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
| CN112584831A (zh) * | 2018-08-16 | 2021-03-30 | 拜奥海芬治疗学有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
| US12383528B2 (en) | 2018-12-10 | 2025-08-12 | The General Hospital Corporation | Cromolyn esters and uses thereof |
| US10559307B1 (en) | 2019-02-13 | 2020-02-11 | Karen Elaine Khaleghi | Impaired operator detection and interlock apparatus |
| WO2021207060A1 (en) | 2020-04-06 | 2021-10-14 | The General Hospital Corporation | Methods of treatment of coronavirus-induced inflammation conditions |
| US12612391B2 (en) | 2020-12-28 | 2026-04-28 | The General Hospital Corporation | Cromolyn derivatives and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
| US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
| CA2375874A1 (en) * | 1999-06-04 | 2000-12-14 | Chris Polman | Use of riluzole for the treatment of multiple sclerosis |
| WO2003083067A2 (en) * | 2002-03-28 | 2003-10-09 | Brigham And Women's Hospital, Inc. | Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease |
| GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| JP2011093849A (ja) * | 2009-10-30 | 2011-05-12 | Kissei Pharmaceutical Co Ltd | トラニラストの易溶性粉末吸入製剤 |
| US9241933B2 (en) * | 2011-03-01 | 2016-01-26 | Pharnext | Compositions for treating amyotrophic lateral sclerosis |
| CN109316480A (zh) * | 2011-07-13 | 2019-02-12 | 赛特凯恩蒂克公司 | 组合als疗法 |
| IN2014DN07989A (enExample) * | 2012-03-01 | 2015-05-01 | Pharnext |
-
2015
- 2015-11-17 CA CA2967659A patent/CA2967659A1/en not_active Abandoned
- 2015-11-17 US US15/100,162 patent/US20180153862A1/en not_active Abandoned
- 2015-11-17 BR BR112017010440A patent/BR112017010440A2/pt not_active Application Discontinuation
- 2015-11-17 KR KR1020177016605A patent/KR20170137030A/ko not_active Withdrawn
- 2015-11-17 SG SG11201703897SA patent/SG11201703897SA/en unknown
- 2015-11-17 EA EA201791110A patent/EA201791110A1/ru unknown
- 2015-11-17 WO PCT/US2015/061106 patent/WO2016081466A1/en not_active Ceased
- 2015-11-17 EP EP15821185.4A patent/EP3220890A1/en not_active Withdrawn
- 2015-11-17 AU AU2015350142A patent/AU2015350142A1/en not_active Abandoned
- 2015-11-17 JP JP2017545857A patent/JP2017535612A/ja active Pending
- 2015-11-17 MX MX2017006454A patent/MX2017006454A/es unknown
- 2015-11-17 CN CN201580073646.5A patent/CN107735077A/zh active Pending
-
2017
- 2017-05-15 IL IL252283A patent/IL252283A0/en unknown
- 2017-05-19 PH PH12017500933A patent/PH12017500933A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017535613A5 (enExample) | ||
| Jee et al. | Impact of sleep disorder as a risk factor for dementia in men and women | |
| Mischoulon et al. | Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence | |
| MacFarlane et al. | Hypnotics in insomnia: the experience of zolpidem | |
| JP2006506378A5 (enExample) | ||
| RU2013154699A (ru) | Сцилло-инозитол для применения в лечении поведенческих и психических расстройств | |
| Almikhlafi | The role of exercise in Parkinson’s Disease | |
| JP2017526693A5 (enExample) | ||
| Winkelman et al. | Current patterns and future directions in the treatment of insomnia | |
| CN104127730A (zh) | 一种治疗神经衰弱的中药及其制备方法 | |
| CN109069466A (zh) | 5-ht6受体拮抗剂用于治疗阿尔茨海默病伴情感淡漠共病 | |
| Shinde et al. | Homoeopathy for post COVID 19 illnesses: a case series | |
| CN103656380A (zh) | 一种治疗帕金森病的药物 | |
| Jung et al. | The Effect of Laughter Therapy on Sleep in the Community-dwelling Elderly. | |
| CN105079350A (zh) | 治疗失眠症的中药组合物 | |
| CN208211856U (zh) | 连体颈舒枕 | |
| CN101439154A (zh) | 用于治疗失眠的天麻药物 | |
| CN101391021B (zh) | 一种中药组合物在制备治疗焦虑症药物中的应用 | |
| CN110680880A (zh) | 一种治疗肝阳上亢型失眠的中药组合物及其用途 | |
| Hajilou | Review of different applications of sildenafil with the focus on its role in Alzheimer's disease | |
| CN106177761B (zh) | 一种抗抑郁的中药组方及其制品 | |
| D’yakonov et al. | Comparative studies of the efficacy of combinations of SSRI antidepressants and antipsychotics in the treatment of recurrent depressive disorder | |
| Kalko et al. | Potential risks and pharmacological safety features of hypnotics. Music therapy as a non-drug way to improve sleep quality | |
| Bakhrushina et al. | THE RELEVANCE OF THE PHARMACEUTICAL DEVELOPMENT OF THE NEW DOSAGE FORMS OF HOPANTENIC ACID | |
| ES2969657T3 (es) | Tratamiento de trastorno de síndrome postraumático |